347 results on '"Bor, R."'
Search Results
2. P356 Long-term outcome of UC patients in clinical remission with different level of mucosal activity: real world, retrospective, multicontinental study
3. P674 Real-world experiences of switching to subcutaneous formulation in IBD patients on maintenance vedolizumab treatment
4. P938 Effectiveness and safety of switching from original infliximab to GP1111 biosimilar in inflammatory bowel diseases – prospective, cohort study
5. 494 Changes in mental well-being after initiating elexacaftor-tezacaftorivacaftor on the group, subgroup, and individual level: a four-wave longitudinal study
6. Comparing loneliness among older migrants and non-migrants in the Netherlands : researching cultural and individual factors of loneliness
7. P309 Accuracy of PanMayo endoscopic score in predicting long-term disease outcomes in ulcerative colitis– a promising scoring system
8. P605 Real life efficacy of tofacitinib in different situation in ulcerative colitis: a retrospective worldwide multicentre collaborative study
9. P739 Sequential treatment is effective to achieve remission and avoid colectomy in moderate-to-severe Ulcerative Colitis refractory to anti-TNF therapy
10. DOP13 Plasma metabolite fingerprint could discriminate inflammatory bowel disease patients from healthy subjects
11. P733 Novelties of COVID-19 vaccination beyond efficacy: Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients
12. Response to Roche letter to editor Re. Cutting edge selection: learning from high reliability organisations for virtual recruitment in surgery during the COVID-19 pandemic
13. DOP007 Efficacy of vedolizumab induction therapy on clinical and endoscopic activity in patients with anti-tumour necrosis factor alpha-resistant inflammatory bowel disease
14. Estimation and expected sample size in Simon's two-stage designs that stop as early as possible
15. P739 Characteristic of IBD related colorectal cancers observed in different Hungarian centers
16. P675 Infliximab biosimilar CT-P13 therapy is effective in maintaining clinical remission in Crohnʼs disease and ulcerative colitis – 54 week data
17. P580 Prognostic factors, effectiveness and safety of endoscopic balloon dilatation for de novo and anastomotic strictures in Crohnʼs disease – a multicenter “real life” study
18. P317 Postoperative complications, outcome, quality of life and self-image after ileal pouch-anal anastomosis in patients operated due to acute, severe or chronic, therapy refractory ulcerative colitis
19. P279 Children born to mothers with inflammatory bowel disease – Is there any risk for newbornsʼ complication and development during the childhood?
20. P713 Gut microbiota alterations after bowel preparation amongst inflammatory bowel disease patients
21. P352 Ustekinumab is associated with superior treatment persistence compared to vedolizumab in Crohn’s disease patients who failed to anti-TNF therapy: results from a Hungarian cohort study
22. P279 Prevalence of iron deficiency in inflammatory bowel disease
23. P721 Faecal microbiota analysis with body composition and nutritional habits simultaneously amongst Crohn’s disease patients
24. P444 COVID-19 risk factors, infection course and vaccination among patients with inflammatory bowel disease based on a Hungarian cohort
25. P572 Therapy optimisation and intravenous ferric carboxymaltose in active or inactive IBD with iron deficiency: it’s time to make iron deficiency part of tight monitoring to reach T2T? – preliminary results of a prospective study
26. Cutting edge selection: learning from high reliability organisations for virtual recruitment in surgery during the COVID-19 pandemic
27. Letter: role of diet in the onset and relapse of inflammatory bowel disease from the patients’ perspective
28. LONG-TERM OUTCOMES AFTER ENDOSCOPIC REMOVAL OF MALIGNANT COLORECTAL POLYPS – RESULTS FROM A RETROSPECTIVE COHORT STUDY
29. P748 Characteristics of inflammatory bowel diseases in different stage of adolescence
30. P676 Faecal monitoring is useful in monitoring treatment response in anti-TNF-treated patients
31. P432 Effects and safety of a colon-long absorbing budesonide product in patients with mild to moderate ulcerative colitis
32. P663 Efficacy of tofacitinib in patients with ulcerative colitis after previous ineffective biological therapies
33. P817 Influence of inflammatory bowel diseases on depression and suicidal risk: a questionnaire-based survey
34. P357 Importance of stool drug monitoring in anti-TNF-treated patients
35. Risk Analysis of Tendering Policies for Capital Projects
36. The sociodemographic profile, risk categories and prevalence of HIV infection among people attending a London same-day testing clinic, 2000-2001
37. The first session with a new client: five stages
38. Accuracy of PanMayo endoscopic score in predicting long-term disease outcomes in ulcerative colitis – a promising scoring system.
39. ePS1.05 High reproducibility of Forskolin-induced swelling of intestinal organoids across three academic laboratories
40. DOUBLE STENTING SEEMS TO BE BETTER THAN DOUBLE BYPASS IN CASE OF COMBINED MALIGNANT BILIARY AND DUODENAL OBSTRUCTION: META-ANALYSIS AND SYSTEMATIC REVIEW
41. P674 Blood thiopurine level, anti-TNF drug level and body composition parameters in inflammatory bowel diseases patients: a cross-sectional study in a Hungarian IBD centre
42. P371 Outcome of immediate infliximab optimisation based on rapid assessment of serum drug and faecal calprotectin concentrations in Crohn’s disease
43. P534 IBD-related malignancies observed in 2015–2018: 4 years’ results from the prospective nationwide Hungarian registry
44. P610 Penetration, short- and long-term efficacy of anti-TNF-α therapy for ulcerative colitis between 2010–2016 in Hungary
45. Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology
46. Apolipoprotein C-I plays a role in the pathogenesis of glomerulosclerosis
47. Open access clinic providing HIV-I antibody results on day of testing: the first twelve months
48. THE INCIDENCE AND CHARACTERISTICS OF INTERVAL COLORECTAL CANCER IN CSONGRAD COUNTY IN HUNGARY
49. OUTCOMES OF ENDOSCOPIC AND SURGICAL REMOVAL OF EARLY COLORECTAL NEOPLASIA
50. P840 IBD-related malignancies and mortalities observed in 2015–2017: 3 years’ results from the prospective nationwide Hungarian registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.